These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 16427342)
1. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors. Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103 [TBL] [Abstract][Full Text] [Related]
3. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis. Albohy A; Li MD; Zheng RB; Zou C; Cairo CW Glycobiology; 2010 Sep; 20(9):1127-38. PubMed ID: 20511247 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1). Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975 [TBL] [Abstract][Full Text] [Related]
5. Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids. Magesh S; Savita V; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M Bioorg Med Chem; 2009 Jul; 17(13):4595-603. PubMed ID: 19450982 [TBL] [Abstract][Full Text] [Related]
6. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092 [TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio). Manzoni M; Colombi P; Papini N; Rubaga L; Tiso N; Preti A; Venerando B; Tettamanti G; Bresciani R; Argenton F; Borsani G; Monti E Biochem J; 2007 Dec; 408(3):395-406. PubMed ID: 17708749 [TBL] [Abstract][Full Text] [Related]
8. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues. Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623 [TBL] [Abstract][Full Text] [Related]
9. New insights on the sialidase protein family revealed by a phylogenetic analysis in metazoa. Giacopuzzi E; Bresciani R; Schauer R; Monti E; Borsani G PLoS One; 2012; 7(8):e44193. PubMed ID: 22952925 [TBL] [Abstract][Full Text] [Related]
10. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells. Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228 [TBL] [Abstract][Full Text] [Related]
11. Nile Tilapia Neu3 sialidases: molecular cloning, functional characterization and expression in Oreochromis niloticus. Chigwechokha PK; Komatsu M; Itakura T; Shiozaki K Gene; 2014 Nov; 552(1):155-64. PubMed ID: 25234733 [TBL] [Abstract][Full Text] [Related]
12. Novel Nile tilapia Neu1 sialidases: Molecular cloning and biochemical characterization of the sialidases Neu1a and Neu1b. Honda A; Chigwechokha PK; Takase R; Hayasaka O; Fujimura K; Kotani T; Komatsu M; Shiozaki K Gene; 2020 Jun; 742():144538. PubMed ID: 32184168 [TBL] [Abstract][Full Text] [Related]
13. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design. Zhou Z; Bates M; Madura JD Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of sialidases in human normal and tumor tissues. Forcella M; Mozzi A; Stefanini FM; Riva A; Epistolio S; Molinari F; Merlo E; Monti E; Fusi P; Frattini M Cancer Biomark; 2018 Feb; 21(3):591-601. PubMed ID: 29278877 [TBL] [Abstract][Full Text] [Related]
15. Mammalian sialidases: physiological and pathological roles in cellular functions. Miyagi T; Yamaguchi K Glycobiology; 2012 Jul; 22(7):880-96. PubMed ID: 22377912 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for substrate specificity of mammalian neuraminidases. Smutova V; Albohy A; Pan X; Korchagina E; Miyagi T; Bovin N; Cairo CW; Pshezhetsky AV PLoS One; 2014; 9(9):e106320. PubMed ID: 25222608 [TBL] [Abstract][Full Text] [Related]
17. Sialidase NEU3 and its pathological significance. Miyagi T; Yamamoto K Glycoconj J; 2022 Oct; 39(5):677-683. PubMed ID: 35675020 [TBL] [Abstract][Full Text] [Related]
18. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies. Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954 [TBL] [Abstract][Full Text] [Related]
19. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803 [TBL] [Abstract][Full Text] [Related]
20. Sialidase expression in activated human T lymphocytes influences production of IFN-gamma. Nan X; Carubelli I; Stamatos NM J Leukoc Biol; 2007 Jan; 81(1):284-96. PubMed ID: 17028199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]